8-K

                SECURITIES AND EXCHANGE COMMISSION
                       WASHINGTON, D.C. 20549
               ------------------------------------

                           FORM 8-K

                        CURRENT REPORT
Pursuant to Section 13 or 15 (d) of The Securities Exchange Act of 1934

  Date of Report (Date Earliest Event Reported)       June 29, 2006

                         BIOSYNERGY, INC.
      (Exact name of Registrant as specified in its charter)

    Illinois                        0-12459               36-2880990
- -----------------------------------------------------------------------
(State or other jurisdiction    (Commission File        (IRS Employer
    or incorporation)                Number)           Identification)

          1940 E. Devon, Elk Grove Village, Illinois 60007
- -----------------------------------------------------------------------
                   (Address of principal executive offices)

Registrant's telephone number, including area code:     (847) 956-0471

                               N/A
- -----------------------------------------------------------------------
      (Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions (see General Instruction A.2.
below):

[ ] Written communications pursuant to Rule 425 under the Securities
Act (17 CFR 230.425)

[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange
Act (17 CFR 240.14a-12)

[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under
the Exchange Act (17 CFR 240.14d-2(b))

[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under
the Exchange Act (17 CFR 240.13e-4(c))

Item 5.02(d) Appointment of Directors
             ------------------------
On June 29, 2006, the Board of Directors of Biosynergy, Inc. (the
"Company") increased the number of directors from three to four and
elected Laurence C. Mead as director of the Company.  Mr. Mead
currently serves the Company as its Chief Operating Officer, Vice
President - Manufacturing, Chief Accounting Officer and Manager of
Financial and Product Development.  Mr. Mead joined the production
department of the Company in 1980, and has been employed as the
Company's Production Manager since 1984.  In April, 1994, Mr. Mead
was appointed Vice President - Manufacturing and Manager of
Financial and Product Development.  Mr. Mead received his Bachelor
of Science degree in August, 1992 from Roosevelt University where he
majored in Accounting.

AGREEMENTS OR ARRANGEMENTS.  There were and are no arrangements or
understandings between Mr. Mead and the other directors or officers
of the Company pursuant to which Mr. Mead was or is to be selected
in the future as a director.

Mr. Mead has not been named as a member of any committee of the
board of directors, and is not expected to be named as a member of
any such committee in the immediate future.

FAMILY RELATIONSHIPS.  There is no family relationship between Mr.
Mead and any other director, executive officer, or person nominated
or chosen by the Company to become a director or executive officer.

INVOLVEMENT IN CERTAIN LEGAL PROCEDINGS.  Laurence Mead is not, nor
has he been, involved in any legal proceedings which are material to
an evaluation of his ability or integrity.

CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS.  With the exception
of payment of salary and other employee benefits otherwise provided
to all employees of the Company, Mr. Mead and the Company have not
entered into any agreement or arrangements which would be deemed
additional compensation to Mr. Mead.  Laurence C. Mead has not been
involved in any transactions with any third party related to or
doing business with the Company during the past two fiscal years
which accrued or will accrue to his benefit.


Item 9.01.  Financial Statements and Exhibits

(c)   Exhibits

      (3)(ii) Amendment to Bylaws of Biosynergy, Inc., dated
June 29, 2006, amending Article III, Section 2 of the Company's
By-Laws.


                            SIGNATURES

           Pursuant to the requirements of the Securities Exchange
Act of 1934, the registrant has duly caused this report to be signed
on its behalf by the undersigned hereunto duly authorized.


                                BIOSYNERGY, INC.


Date:     June 29, 2006         By:   /s/ Fred K. Suzuki /s/
                                   -------------------------------
                                   Fred K. Suzuki, President

                                By:   /s/ Lauane C. Addis /s/
                                   -------------------------------
                                   Lauane C. Addis, Secretary

EX-1

                             AMENDMENT TO BY-LAWS
                                      OF
                                BIOSYNERGY, INC.



	Effective June 29, 2006, the Board of Directors Amended the
By-Laws of Biosynergy, Inc. (the "Company") by unanimous vote of the
members of the Board of Directors as follows:


                                 ARTICLE III

	SECTION 2.	   NUMBER, TENURE AND QUALIFICATIONS.  The number of
directors of the Corporation shall be four (4).  Each director shall
hold office until the next annual meeting of the shareholders or until
his successor has been elected and qualified.  Directors need not be
residents of Illinois or shareholders of the Corporation.  The number of
directors may be increased or decreased from time to time by amendment of
this Section, but no decrease shall have the effect of shortening the term
of any incumbent director.


	The undersigned, being the Secretary of the Company, hereby
certifies that the above Amendment was adopted on June 29, 2006 by unanimous
vote of the members of the board of directors of the Company.


                                            /s/ Lauane C. Addis /s/
							----------------------------------
							Lauane C. Addis, Secretary